Cancer Screening and Peace of Mind: What Testing Can (and Can’t) Provide

Cancer screening can help you detect cancer before you develop symptoms. Finding cancer in these early stages can increase treatment options, improve outcomes, and even decrease the cost of treating cancer. In some cases, cancer screening can find precancerous conditions and allow treatment that can prevent cancer altogether. [1]

There are several types of cancer screening tests available. Some of the common ones include [1]:

• Breast cancer: Mammograms
• Cervical cancer: Pap smears
• Colorectal cancer: Fecal immunotesting (FIT), fecal occult blood testing, colonoscopy
• Prostate cancer: PSA
• Lung Cancer: Low-dose CT scan
• Blood tests for cancer detection

The types of testing and how frequently they should be performed vary based on your individual risk factors, including health, family history, and lifestyle.

Not all tests that detect cancer make good screening tests. Four primary features make a screening test “good”. [2]

1. Detects cancer or precancerous cells early, when still asymptomatic
2. It can detect cancer at a stage that is easier to treat
3. Finding and treating cancer early increases the survival rate
4. Testing is reliable and accurate, and has a low rate of false-positive [JF1] and false-negative results

It’s important to note that cancer screening tests are not the same as diagnostic tests. An abnormal cancer screening test does not automatically mean you have cancer; it simply indicates that you need more testing. Screening tests also have the potential to be falsely positive or negative, which can cause increased anxiety or even a missed diagnosis.

One of the most important benefits of cancer screening is to find cancer at an early stage, typically before symptoms occur. When cancer is detected early, there are often more treatment options available. Catching cancer early, when it is more treatable, often increases the survival rate and may even minimize side effects from treatment. [3]

Another major benefit is cancer screening peace of mind. Having a negative cancer screening test does not mean that you will never develop cancer, but it offers reassurance that the specific type of cancer that is being screened for is not present. False negatives (having a negative test despite cancer actually being present) are possible, but this is typically rare. [4] Routine screening can help decrease the impact of false negatives. The emotional impact of screening is a significant benefit of staying up-to-date on your routine preventive care.

On a population level, cancer screening programs may decrease healthcare costs and lead to declines in cancer overall. [5] Screening is not perfect, but the overall benefits of testing are substantial. Like any test, cancer screening also has limitations.

While cancer screening has many important benefits, there are also limitations that must be taken into account. False-positive or false-negative testing is a potential drawback.

False positive testing means that the test suggests a cancer may be present when it is not. This can cause unnecessary anxiety and the need for other potentially invasive testing that can carry additional risk. False negative testing means that cancer is present despite negative testing. This can lead to a delayed diagnosis. [6]

Another potential limitation of cancer screening is overdiagnosis or overtreatment. This means that cancers are detected that would not have caused harm during the person’s lifetime. These cancers are often treated, which can result in side effects and risks of treatments that may not be necessary. [7]

Screening tests may not be as effective in people who are at a higher risk for cancer or who have certain risk factors. This is one reason why it is important to talk to your healthcare provider when choosing the right screening test for you.

For people who are concerned about their health or worried about their cancer risk factors, cancer screening can play a large role in peace of mind. Normal screening can offer reassurance that cancer is unlikely to be present.

When cancer screening does identify an abnormality, it can give you a sense of empowerment knowing that you can take action to control your health and may be able to improve your outcome. Finding a possible cancer before symptoms develop means that you can get timely follow-up and management.

This is especially true if you have a family history, known genetic risk, or other risk factors for cancer. Knowing you are at an increased risk of cancer can cause anxiety, and regular health screenings, including cancer screening, give you steps you can take to protect your health. Screening doesn’t eliminate all risk, so it is important to understand what cancer screening can tell you, and what it can’t.

Cancer screening offers many benefits, but it is also important to understand what it can’t provide.

Negative cancer screening tests do not guarantee that cancer will not develop in the future. A normal cancer screening test means that there is a low likelihood that the specific cancer tested is present at the time of testing. The normal cancer screening also only applies to the cancer being tested, not to all cancers.

Cancer screening does not prevent cancer from occurring, though it may allow the detection of precancerous changes that can be treated before cancer develops.

Screening tests don’t differentiate between aggressive cancers that can shorten your life span and cancers that are unlikely to ever cause harm. Finding a cancer that is not likely to cause harm may lead to a risk of overtreatment.

Cancer screening may decrease anxiety and provide peace of mind, but it doesn’t eliminate uncertainty completely. False positives and false negatives are possible, though tests are designed to minimize this risk. Screening is not a substitute for regular medical care or healthy lifestyle choices.

If you’re looking to learn more about cancer screening for your peace of mind or just to stay current on your preventive health maintenance, Everlywell is here for you. We have a range of tests available for everything from cancer screening to metabolic health. The Galleri® Multi-Cancer Early Detection Test uses cell-free DNA to detect more than 50 types of cancer. We also offer fecal immune testing (FIT) for colon cancer screening.

At Everlywell, we also offer a range of at-home tests to help inform your healthcare journey. Our virtual care visits give you access to a certified healthcare provider who can answer questions and make cancer screening recommendations tailored to your health and risk factors. At Everlywell, you come for the testing but stay for the guidance.

Resources

1. Moleyar-Narayana P, Leslie SW, Ranganathan S. Cancer screening. StatPearls - NCBI Bookshelf. Published May 31, 2024. Accessed February 17, 2026. https://www.ncbi.nlm.nih.gov/books/NBK563138/
2. Cancer screening overview. Cancer.gov. Published October 20, 2023. Accessed February 17, 2026. https://www.cancer.gov/about-cancer/screening/patient-screening-overview-pdq
3. Bretthauer M, Wieszczy P, Løberg M, et al. Estimated lifetime gained with cancer screening tests. JAMA Internal Medicine. 2023;183(11):1196. doi:10.1001/jamainternmed.2023.3798. https://pmc.ncbi.nlm.nih.gov/articles/PMC10463170/
4. Professional CCM. Cancer screening. Cleveland Clinic. Published May 6, 2025. Accessed February 17, 2026. https://my.clevelandclinic.org/health/diagnostics/24118-cancer-screening
5. Lew JB, Feletto E, Wade S, et al. Benefits, harms, and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates. Public Health Research & Practice. 2019;29(2). doi:10.17061/phrp2921913. https://connectsci.au/pu/article/29/2/e2921913/265250/Benefits-harms-and-cost-effectiveness-of-cancer
6. Shreffler J, Huecker MR. Diagnostic testing accuracy: sensitivity, specificity, predictive values and likelihood ratios. StatPearls - NCBI Bookshelf. Published March 6, 2023. Accessed February 17, 2026. https://www.ncbi.nlm.nih.gov/books/NBK557491/
7. Srivastava S, Koay EJ, Borowsky AD, et al. Cancer overdiagnosis: a biological challenge and clinical dilemma. Nature Reviews Cancer. 2019;19(6):349-358. doi:10.1038/s41568-019-0142-8. https://pmc.ncbi.nlm.nih.gov/articles/PMC8819710/